Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $548.9300 (1.75%) ($548.9300 - $548.9300) on Mon. Jan. 25, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.83% (three month average) | RSI | 81 | Latest Price | $548.9300(1.75%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.2% a day on average for past five trading days. | Weekly Trend | REGN advances 5.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) XLV(43%) SPLV(37%) DIA(36%) IVW(36%) | Factors Impacting REGN price | REGN will decline at least -0.915% in a week (0% probabilities). VIXM(-21%) UUP(-7%) TBT(-7%) VXX(-6%) IGOV(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.915% (StdDev 1.83%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $540.3(1.6%) | 10 Day Moving Average | $526.94(4.17%) | 20 Day Moving Average | $506.03(8.48%) | To recent high | -6.8% | To recent low | 16.8% | Market Cap | $58.202b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |